Herbas VPB

Print
EN | LT
LT - LPA antagonistai
EN - LPA ANTAGONISTS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 401/14 (2006.01)
C07D 401/04 (2006.01)
C07D 249/06 (2006.01)
A61K 31/4192 (2006.01)
A61K 31/4439 (2006.01)
A61P 11/06 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 3666771
(13) Kind of document T
(96) European patent application number 20154651.2
Date of filing the European patent application 2017-06-20
(97) Date of publication of the European application 2020-06-17
(45) Date of publication and mention of the grant of the patent 2021-09-29
(46) Date of publication of the claims translation 2021-12-10
Priority applications
(30) Number Date Country code
201662352792 P 2016-06-21 US
Inventors
(72)
Cheng, Peter Tai Wah , US
Kaltenbach, Robert F. III , US
Li, Jun , US
Shi, Jun , US
Shi, Yan , US
Tao, Shiwei , US
Zhang, Hao , US
Dhanusu, Suresh , IN
Selvakumar, Kumaravel , IN
Reddigunta, Ramesh Babu , IN
Walker, Steven J. , US
Kennedy, Lawrence J. , US
Corte, James R. , US
Fang, Tianan , US
Jusuf, Sutjano , US
Grantee
(73) Bristol-Myers Squibb Company , Route 206 & Province Line Road, Princeton, NJ 08543, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) LPA antagonistai
  LPA ANTAGONISTS
Last renewal fee
Payment date Validity (years) Amount
2025-05-19 9 208.00 EUR
Next renewal fee
2026-06-20